India's Nanomedicine Development and Government Support
Union Minister Dr. Jitendra Singh announced at the World Congress on Nanomedicine 2026 that India is significantly investing in nanomedicine research and development, with the Department of Biotechnology supporting 210 R&D projects with financial support of ₹174 crore. The Minister described nanomedicine as one of the most transformative developments in medical practice, working at the nanometre scale (one-billionth of a metre) to enable precision medicine and personalized healthcare based on individual genetic profiles, lifestyle factors, and environmental influences.
The funded projects cover multiple therapeutic areas including targeted drug delivery, cancer nanomedicine, infectious-disease nanomedicine, nucleic-acid and vaccine delivery, nano-diagnostics and imaging, regenerative medicine and wound healing, as well as nanotoxicology and regulatory science. Specific promising research areas mentioned include oral insulin nanoparticles that address absorption and digestive enzyme challenges, nanobots for breast cancer treatment, precision nanoinjection, and targeted breast cancer nanomedicine.
Regulatory Framework and Ecosystem Development
India has established a comprehensive regulatory framework for nanopharmaceuticals through guidelines jointly developed by the Department of Biotechnology (DBT), Indian Council of Medical Research (ICMR), and Central Drugs Standard Control Organisation (CDSCO). This framework provides standards for evaluating the safety, quality and efficacy of nanopharmaceutical products. The ecosystem extends beyond research to include startup support through BIRAC (Biotechnology Industry Research Assistance Council) with programs including Biotechnology Ignition Grant (BIG), Promoting Academic Research Conversion to Enterprise (PACE), Small Business Innovation Research Initiative (SBIRI) and Biotechnology Industry Partnership Programme (BIPP) to help translate research into commercial enterprises and products.
International Context and Event Details
The World Congress on Nanomedicine 2026, hosted by the Institute of Nano Medical Sciences (INMS), Faculty of Medical Sciences, University of Delhi, brought together over 2,000 participants including eminent scientists and young researchers. The event was chaired by Nobel Laureate Prof. Roger D. Kornberg from Stanford University, USA, with Prof. T.M.S. Chang from McGill University, Canada as Honorary President. Prof. Kornberg emphasized that nanomedicine offers precision in delivering the right amount of treatment to the right place at the right time, improving effectiveness while reducing toxicity across drug delivery, diagnosis, imaging and regenerative medicine applications.
Dr. Singh cautioned that while technologies like Artificial Intelligence and nanotechnology open new possibilities, they must complement rather than compromise clinical judgment, emphasizing the need to synergize advanced technology with human clinical dimensions while maintaining foundational diagnostic skills in medical education.